This Is MS Multiple Sclerosis Community: Knowledge & Support

Yahoo!My Yahoo!Mail Make Y! your home pageYahoo! SearchSearch:Welcome, retired_at_40_01
Finance Home -Help


Home InvestingMarket OverviewMarket StatsStocksMutual FundsETFsBondsOptionsIndustriesCurrencyEducationNews & OpinionMarketsInvesting IdeasExpert AdviceSpecial EditionsCompany FinancesProvidersPersonal FinanceBanking & BudgetingCareer & WorkCollege & EducationFamily & HomeInsuranceLoansReal EstateRetirementTaxesHow-to GuidesGet QuotesSymbol LookupFinance Search New! Find Quotes Faster
You no longer need to remember symbols. Simply type in a company name or stock symbol for instant results.

Learn more... Close x 7811759



Press Release Source: Geron Corporation


Data Show ...

http://news.bbc.co.uk/1/hi/health/7049601.stm

Published: Thursday, 18-Oct-2007
Printer Friendly Email to a Friend




Researchers are discovering new ways to help 'de-program' specialised cells so that they can be re-programmed to form a range of different types of tissue, an international meeting of stem cell biologists was told.
If this approach can be made to succeed, it could circumvent many of the ethical and moral objections that have been raised to using human stem cells derived from embryos - the ...

As a positive sort of person (in terms of future prospects for those with MS), I have real hope for the stem cell pilot trial taking place in Bristol, England. Further detail on the pilot trial are attached. Similar trials are taking place around the world. Attached is an article about a trial in Lebanon.

Ian

http://www.mstrust.org.uk/downloads/ste ... 0trial.doc

http://c.moreover.com/click/here.pl?j11 ... 2&w=464753

The pharmaceutical industry on Tuesday announced its first direct involvement in research using human embryonic stem cells.

Three companies have set up a consortium with the government to develop stem cells for safety testing of new drugs through a public-private partnership. The launch of Stem Cells for Safer Medicines, or SC4SM, is significant because “big pharma” has been reluctant to engage in embryonic stem cell research.

Companies fear the reaction in markets such as the ...

Here is a report of the work being undertaken by Professor Scolding. I like its optimism!. 8)

http://www.telegraph.co.uk/news/main.jhtml?xml=/news/2007/09/28/nstem128.xml

J

I just watched this show on PBS called Innovation which discussed how stem cells are being used to help heal spinal chord injuries and damaged heart tissue following a heart attack. The show is from 2004 so the information might be a little dated but it was great to see the success in these areas. It would be really interesting to see a followup of this show to learn how these patients are doing now ...

I saw this article title in Pubmed:

Regeneration of myelin in multiple sclerosis. The role of mesenchymal cells in such regeneration and in myelin formation in the peripheral nervous system.

Sounds pretty interesting to me. It's the kind of article that is relevant to the mesenchymal stem cell research that's being done today. The source of the article?

Neurology. 1966 Apr;16(4):364-72.
Feigin I, Popoff N.

Yes, 1966!


Anyhow, I was digging around for info on ...

Dear all,

One of the UK's leading lights looking at stem cell therapies for MS is Professor Neil Scolding who is based in Bristol, England. He has been doing work for a number of years and is being funded by the UK MS Society. It now looks as if the first human trial using bone-marrowed derived stem cells has started at Bristol. It is early days, but this is a bona fide trial - not ...

Another good step in the process of figuring out stem cells:



Functioning Neurons From Human Embryonic Stem Cells Produced

10 August 2007 -- Scientists with the Institute of Stem Cell Biology and Medicine at UCLA were able to produce from human embryonic stem cells a highly pure, large quantity of functioning neurons that will allow them to create models of and study diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, prefrontal dementia and schizophrenia, etc.

Researchers ...